News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Bayer HealthCare to Test Drug to Treat Eye Disease in Asia
January 18, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Yahoo -- German drugmaker Bayer will launch a phase III trial in several Asian countries this year to test a compound to treat an eye disease related to severe shortsightedness.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 3
Asia
Europe
MORE ON THIS TOPIC
Insights
France’s biotech ecosystem: science, capital and scale
May 28, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Rare diseases
FDA accepts BridgeBio’s application for potential first limb-girdle muscular dystrophy drug
May 27, 2026
·
3 min read
·
Heather McKenzie
Immunology and inflammation
Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly’s Ebglyss
May 27, 2026
·
3 min read
·
Annalee Armstrong
Vaccines
Lilly just bought renowned regulator Peter Marks a pipeline to play with
May 27, 2026
·
2 min read
·
Annalee Armstrong
